Cargando…
Designing of a Novel Fusion Protein Vaccine Candidate Against Human Visceral Leishmaniasis (VL) Using Immunoinformatics and Structural Approaches
Leishmaniasis is caused by an obligate intracellular protozoan parasite. The clinical forms of leishmaniasis differ from cutaneous leishmaniasis, mucocutaneous leishmaniasis and visceral leishmaniasis (VL) which depend on the parasite species and the host’s immune responses. There are significant ch...
Autores principales: | Atapour, Amir, Ghalamfarsa, Farideh, Naderi, Samaneh, Hatam, Gholamreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067785/ https://www.ncbi.nlm.nih.gov/pubmed/33935610 http://dx.doi.org/10.1007/s10989-021-10218-8 |
Ejemplares similares
-
Immunoinformatics Approach to Design a Novel Subunit Vaccine Against Visceral Leishmaniasis
por: Lari, Alireza, et al.
Publicado: (2021) -
A multi-epitope vaccine designed against blood-stage of malaria: an immunoinformatic and structural approach
por: Atapour, Amir, et al.
Publicado: (2022) -
Assessment of treatment outcomes of visceral leishmaniasis (VL) treated cases and impact of COVID-19 on VL management and control services in Bangladesh
por: Maruf, Shomik, et al.
Publicado: (2023) -
Screening and identification of potential inhibitor for visceral leishmaniasis (VL) through computational analysis
por: Shaslinah, N., et al.
Publicado: (2022) -
Assessment of the impact of implementation research on the Visceral Leishmaniasis (VL) elimination efforts in Nepal
por: Joshi, Anand Ballabh, et al.
Publicado: (2023)